A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer
Authors
Keywords
Small cell lung cancer, CD44, Hyaluronic acid, Cancer stem cells
Journal
INVESTIGATIONAL NEW DRUGS
Volume 36, Issue 2, Pages 288-298
Publisher
Springer Nature
Online
2017-12-26
DOI
10.1007/s10637-017-0555-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis
- (2017) D. Han et al. EUROPEAN JOURNAL OF CANCER CARE
- Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
- (2017) Raheleh Roudi et al. Cancer Biomarkers
- Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial
- (2015) Yuankai Shi et al. Thoracic Cancer
- Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis
- (2014) Shuang Zhao et al. Asian Pacific Journal of Cancer Prevention
- Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity
- (2013) Elisa Dalla Pozza et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
- (2013) Shanthi Ganesh et al. BIOMATERIALS
- Cancer Stem–like Cell Marker CD44 Promotes Bone Metastases by Enhancing Tumorigenicity, Cell Motility, and Hyaluronan Production
- (2013) Toru Hiraga et al. CANCER RESEARCH
- CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status
- (2013) Jurrit Zeilstra et al. PLoS One
- The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. THORAX
- Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
- (2012) Tateaki Naito et al. Journal of Thoracic Oncology
- A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
- (2011) A. Schmittel et al. ANNALS OF ONCOLOGY
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
- (2010) P. Zatloukal et al. ANNALS OF ONCOLOGY
- Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial
- (2010) Peter Gibbs et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer
- (2009) Gigi Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- A Pilot Human Evaluation of a Formulation of Irinotecan and Hyaluronic Acid in 5-Fluorouracil-Refractory Metastatic Colorectal Cancer Patients
- (2008) Peter Gibbs et al. CHEMOTHERAPY
- Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
- (2008) Andreas Hermes et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started